MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Personalis ROCE Ratio 2011-2025 | PSNL
Annual ROCE Ratio Personalis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -33.64 | -84.93 | -52.96 | -21.06 | -21.62 | -20.89 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -20.89 | -84.93 | -39.18 |
Quarterly ROCE Ratio Personalis
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -42.17 | -37.21 | -40.83 | -39.31 | -59.68 | -71.42 | -70.77 | -50.16 | -61.41 | -52.29 | -48.43 | -31.65 | -37.09 | -31.29 | -25.16 | -13.44 | -18.39 | -17.9 | -18.36 | -14.76 | -20.13 | -20.55 | -19.49 | -14.27 | -12.62 | -5.61 | 1.69 | 5.13 | 5.13 | 3.49 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.13 | -71.42 | -28.63 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 19.29 | -1.73 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 21.26 | -2.34 % | $ 229 M |  China |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
-293.94 | $ 1.52 | -0.65 % | $ 1.93 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
1.9 | $ 40.09 | -0.27 % | $ 1.11 B | USA |
 |
Danaher Corporation
DHR
|
9.82 | $ 231.47 | 0.28 % | $ 169 B | USA |
 |
DarioHealth Corp.
DRIO
|
-66.97 | $ 10.04 | -0.99 % | $ 285 M | Israel |
 |
DexCom
DXCM
|
28.89 | $ 67.42 | 0.84 % | $ 26 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-36.48 | $ 101.54 | -0.05 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 27.01 | -0.55 % | $ 817 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-77.82 | $ 19.73 | -1.45 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
-97.97 | $ 102.61 | 0.25 % | $ 4.05 B | USA |
 |
Anixa Biosciences
ANIX
|
-69.16 | $ 3.42 | 3.64 % | $ 109 K | USA |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 0.24 | -1.79 % | $ 7.04 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
36.29 | $ 226.02 | 0.39 % | $ 41 B | USA |
 |
Guardant Health
GH
|
317.65 | $ 102.38 | -0.12 % | $ 12.6 B | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 135.32 | -0.64 % | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
6.57 | $ 203.16 | 0.14 % | $ 10.4 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-281.17 | $ 5.1 | - | $ 2.74 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 26.98 | 0.37 % | $ 20 B |  Niderland |
 |
Quidel Corporation
QDEL
|
69.35 | $ 28.91 | 1.12 % | $ 1.22 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.86 | $ 175.92 | 0.48 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
-41.6 | $ 6.82 | 1.04 % | $ 884 M | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
13.5 | $ 254.46 | 0.52 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 183.68 | 0.33 % | $ 15.2 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
50.7 | $ 688.18 | 0.86 % | $ 56.8 B | USA |
 |
Lantheus Holdings
LNTH
|
42.0 | $ 66.68 | 0.23 % | $ 4.61 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 417.16 | 0.18 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
25.0 | $ 138.32 | -0.03 % | $ 42 B | USA |
 |
Myriad Genetics
MYGN
|
-17.62 | $ 6.55 | -0.15 % | $ 593 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.9 | $ 45.48 | -0.29 % | $ 10.1 B | Niderland |
 |
Biomerica
BMRA
|
-125.14 | $ 2.65 | 1.15 % | $ 6.09 M | USA |
 |
Bioventus
BVS
|
-47.08 | $ 7.38 | -1.99 % | $ 462 M | USA |
 |
NeoGenomics
NEO
|
-6.89 | $ 12.3 | -0.97 % | $ 1.56 B | USA |